Decibel Cannabis Company Inc. Achieves Initial Closing in Offering
Decibel Cannabis Company Inc. (NASDAQ: DBCCF) recently announced a significant milestone in its journey by completing the first closing of a non-brokered private placement. This private placement was previously revealed to the public, setting a targeted gross proceeds of up to $3,500,000 from the sale of 58,333,333 common shares at a price of $0.06 each. The success of this initial closing highlights the strong support from insiders, further reinforcing Decibel's position in the cannabis market.
Details of the Private Placement
During this first closing, Decibel has effectively raised around $2,010,232 by issuing 33,503,864 common shares. Notably, no finders' fees were associated with this transaction, signifying a direct and efficient approach to capital raising. Benjamin Sze, the CEO of Decibel, emphasized the importance of this initial tranche, noting that over 75% of the participants were insiders, employees, and consultants. This level of insider engagement demonstrates their dedication to the company’s growth and future prospects.
Intended Use of Proceeds
The funds acquired through this offering are earmarked for general working capital purposes and will also facilitate the integration of AgMedica BioScience Inc. into Decibel’s existing operations. This strategic acquisition is aimed at enhancing the company’s product offerings and market reach as it expands its footprint within the cannabis sector.
Future Expectations and Regulatory Approval
Looking ahead, the offering is subject to various regulatory approvals, including the final endorsement from the TSX Venture Exchange (TSXV). The common shares distributed during this offering will observe a hold period that lasts for four months and one day post-issuance, with certain exemptions for specific employees. There is optimism within the company regarding additional closings of the private placement, expected to occur before the end of the month.
Director Participation in the Offering
Inevitably, the involvement of directors and officers in the first closing, where they subscribed for a substantial 18,626,728 common shares, highlights a significant confidence in the future of Decibel. This reflects their belief in the company's potential and direction, as such participation is classified as a "related party transaction" under existing regulations.
About Decibel Cannabis Company Inc.
Decibel is a consumer-focused cannabis company dedicated to innovation and quality in its product offerings. Through its popular brands such as General Admission, Qwest, and Vox, Decibel aims to enchant customers while simultaneously expanding its market presence internationally. Operating state-of-the-art facilities in various regions, including processing in Calgary, Decibel continues to aim for excellence in the rapidly evolving cannabis industry.
Frequently Asked Questions
What is the main goal of Decibel's recent private placement?
The primary aim is to raise funds for working capital and to integrate AgMedica BioScience Inc. into its operations.
How much did Decibel raise in the first closing of the offering?
Decibel raised approximately $2,010,232 by issuing 33,503,864 common shares in this initial closing.
Who participated in the private placement?
Over 75% of the first tranche participants were insiders, employees, and consultants of Decibel, highlighting strong internal support.
What will the raised funds primarily be used for?
The proceeds will be utilized for general working capital needs and to support the integration of AgMedica BioScience into Decibel’s business.
What is Decibel's vision moving forward?
Decibel aims to strengthen its market presence and continue delivering quality cannabis products while remaining committed to innovation.
